Business Wire

Egon Zehnder Accelerates Opportunities for Female Leaders with 2018 Leaders & Daughters Global Event Series

1.3.2018 09:00:00 EET | Business Wire | Press release

Share

Egon Zehnder, the world’s leadership advisory firm, today announced its fourth annual global event series “Leaders & Daughters: Mind the Gap.” This inspiring 40-city program showcases Egon Zehnder’s commitment to diversity while encouraging and accelerating opportunities for female leaders of the future.

Egon Zehnder has a long standing commitment to diversity and is dedicated to ending the glass ceiling effect that exists as women rise in seniority but do not reach the C-Suite. For its 2018 theme, Egon Zehnder and event participants will explore how best to “Mind the Gap,” seeking greater understanding of the limitations women face in reaching senior roles and the conditions that most impact their ambitions. By bringing together today’s most renowned leaders and their daughters, mentees or the women they sponsor, the events foster a dialogue and frame actionable solutions to help women achieve their highest potential.

“Leaders & Daughters continues be a global catalyst for positive change to support professional women at all stages of their careers,” stated Rajeev Vasudeva, Chief Executive Officer of Egon Zehnder. The multiple viewpoints gathered across the globe form a rich perspective to inform how we can pragmatically improve the opportunities and lessen the obstacles for women to succeed,” he noted. “Without the commitment of the world’s top leaders to serve as role models in this journey we won’t accelerate the pace of change.

Launching to coincide with International Women’s Day, 2018 “Leaders & Daughters: Mind the Gap” events kickoff March 5th in Sao Paulo and finish in Jakarta on May 9th. Events will be held in the following cities worldwide:

                 

March 5th

March 8th

March 16th

April 12th

Sao Paolo

Brussels

Beijing

Lisbon

Buenos Aires

Montreal

March 6th

Madrid

March 20th

New Delhi/Bangalore/Mumbai

 

Boston

Shanghai

Hong Kong

Dallas

Sydney

Prague

Tokyo

March 21st

April 17th

Atlanta

Milan

March 7th

March 13th

Istanbul

Bogota

San Francisco/Palo Alto

Santiago

April 18th

London

New York

Washington D.C.

March 15th

March 26th

 

Chicago

Houston

April 25th

 

Johannesburg

Amsterdam

 

Melbourne

March 29th

 

Miami

Toronto

May 9th

 

Seoul

Jakarta

 

Egon Zehnder is resuming its “To My Daughter” campaign, initiated in 2017. Through “To My Daughter,” men and women share their hopes, dreams, insights and practical advice for their own daughters and mentees.

To learn more about Egon Zehnder’s “Leaders & Daughters: Mind the Gap” event series, visit www.egonzehnder.com/leaders-and-daughters. Join the conversation at #LeadersandDaughters or share a To My Daughter letter and photo here.

About Leaders & Daughters: Mind the Gap

Egon Zehnder introduced the Leaders & Daughters event series in 2015 bringing together generations of leaders to explore how to collectively create greater opportunities for all women to reach their highest potential. Over the last few years, Leaders & Daughters events have been attended by more than 5,000 people across every major geography. In 2018, Egon Zehnder hosts Leaders & Daughters events in nearly 40 cities worldwide, addressing the female leadership pipeline challenge and why women leave the workforce on their accent to the top, and how to get them to stay.

About Egon Zehnder

Egon Zehnder is the world’s leadership advisory firm, sharing one goal: To transform people, organizations and the world through great leadership. We know what great leaders can do and are passionate about delivering the best leadership solutions for our clients. As One Firm, our more than 450 Consultants in 68 offices and 40 countries globally bring our individual strengths to form one powerful, collaborative team. We partner closely with public and private corporations, family-owned enterprises and non-profit and government agencies to provide board advisory services, CEO search and succession, executive search, executive assessment, leadership development and cultural and organizational transformation. We share a commitment and pride in doing work that contributes to shaping successful leaders, stronger companies and a better world. For more information visit www.egonzehnder.com and follow us on LinkedIn and Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:
Egon Zehnder
Hilary Crnkovich, +1 312 260 8978
Global Head of Marketing and Communications
hilary.crnkovich@egonzehnder.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 18:51:00 EEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 17:25:00 EEST | Press release

Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensuring your investment is delivering.” The rapid growth of the residential solar market created a growing population of “orphaned” solar sy

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 15:05:00 EEST | Press release

A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is designed to interpret cardiac MRI scans by connecting moving images of the heart with corresponding clinical radio

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 15:00:00 EEST | Press release

Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The research challenges long-held assumptions about media value, showing that not all impressions are equal. Live sports rem

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 15:00:00 EEST | Press release

Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer cell killing activity,” said David Weinreich, MD, MBA, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck. “The Phase 3 study and the enrollment of the first patient with Precem-TcT build on the Company’s more than 20 years of expertise in colorectal cancer, and highlight our commitment to advancing differentiated ADCs for heavily pretreated patients with limited treatment options.” The PROCEADE®-CRC-03 study

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye